How many of us routinely use Vitamin A supplementation in pregancy?? WHO remarks:-"-Although pregnant women are susceptible to vitamin A deficiency throughout gestation, deficiency is most common in the third trimester due to accelerated fetal development and the physiological increase in blood volume during this period . In a pregnant woman with moderate vitamin A deficiency, the fetus can still obtain sufficient vitamin A to develop appropriately, but at the expense of the maternal vitamin A stores .
Vitamin A deficiency may also occur during periods when infectious disease rates are high and/or during seasons when food sources rich in vitamin A are scarce . The prevalence of night blindness (a consequence of
vitamin A deficiency) is also more common in the third trimester of pregnancy, and populations with a prevalence >5% are considered to have a significant public health problem with regard to vitamin A deficiency
. It is currently estimated that 9.8 million pregnant women are affected by night blindness worldwide
There is some indication that low doses of vitamin A supplements given on a daily or weekly basis, starting in the second or third trimester, can reduce the severity of decline in maternal serum retinol levels during late pregnancy and the symptoms of night blindness . One study has suggested that 12 weeks of supplementation is needed to prevent decline in serum retinol levels .
Vitamin A is available in multiple vitamin formulations for prenatal care in some countries. When provided alone, the compounds most commonly used are retinyl palmitate and retinyl acetate in tablet form or oil-based solutions. Alternative forms of delivery include fish liver oils, p-carotene, and a combination of p-carotene and vitamin A. Recommended doses of vitamin A supplements are generally well tolerated by pregnant women; however, vitamin A may become toxic for the mother and her fetus when levels of intake exceed 10 000 IU daily or 25 000 IU weekly . p- carotene, a precursor of vitamin A, may be preferred over vitamin A supplements in pregnant women because excess of p-carotene is not known to cause birth defects .
📷The symptoms of acute vitamin A toxicity include dizziness, nausea, vomiting, headaches, blurred vision, vertigo, reduced muscle coordination, skin exfoliation, weight loss and fatigue . Toxicity generally results from excessive ingestion of vitamin A supplements but regular intake of large amounts of liver, although usually not a problem in vitamin A-deficient areas, may also result in toxicity due to its high content of vitamin A .
Two Cochrane systematic reviews assessing the effects and safety of vitamin A supplementation in pregnant women were updated for this guideline . The first review evaluated the effectiveness of vitamin A (or one of its derivatives) supplementation in pregnancy, alone or in combination with other vitamins and minerals, in relation to maternal and newborn outcomes . It showed that giving vitamin A supplements to women during pregnancy had no effect on the risk of maternal mortality (three trials: risk ratio (RR) 0.78; 95% confidence interval (CI) 0.551.10), perinatal mortality (one trial: RR 1.01; 95% CI 0.95-1.07), neonatal mortality (three trials: RR 0.97; 95% CI 0.90-1.05) or stillbirth (one trial: RR 1.06; 95% CI 0.98-
📷
1.14). In one trial, vitamin A supplementation reduced the risk of maternal night blindness (RR 0.70; 95% CI 0.60-0.82). All trials that investigated maternal and perinatal mortality used weekly supplementation with vitamin A. WHO performed an additional meta-analysis after excluding one study conducted only in HIV-positive pregnant women. The only critical outcome affected by the removal of this study was neonatal mortality, although the effect of vitamin A supplementation remained nonsignificant (two trials: RR 1.00; 95% CI 0.88-1.14) (Annex 1).
The second review evaluated the effectiveness and safety of vitamin supplementation with regard to the risk of spontaneous miscarriage, maternal adverse outcomes and fetal and infant adverse outcomes (21). The review found no difference in total fetal loss (including miscarriages or combined miscarriages and stillbirths) in women given vitamin A compared with placebo (one trial: RR 1.04; 95% CI 0.92-1.17), p-carotene compared with placebo (one trial: RR 1.03; 95% CI 0.911.16), vitamin A with or without multivitamins compared with multivitamins (excluding vitamin A) or placebo (one trial: RR 0.80; 95% CI 0.53-1.21), or vitamin A plus iron and folic acid compared with iron and folic acid (three trials: RR 1.01; 95% CI 0.61-1.66). Similarly, there was no difference in the rates of stillbirth and neonatal deaths between women given any type of vitamin A, alone or in combination with p- carotene, multivitamins or iron and folic acid, compared with controls.
📷The overall quality of the available evidence for maternal mortality was high, whereas for all other critical outcomes it was moderate .
• Vitamin A supplementation is not recommended during pregnancy as part of routine antenatal care for the prevention of maternal and infant morbidity and mortality (strong recommendation[1]).
• In areas where there is a severe public health problem related to vitamin A deficiency vitamin A supplementation during pregnancy is recommended for the prevention of night blindness (strong recommendation1).
A strong recommendation is one for which the guideline development group is confident that the desirable effects of adherence outweigh the undesirable effects. The recommendation can be either in favour of or against an intervention. Implications of a strong recommendation for patients are that most people in their situation would desire the recommended course of action and only a small proportion would not. For clinicians the implications are that most patients should receive the recommended course of action, and that adherence to this recommendation is a reasonable measure of good-quality care. With regard to policy-makers, a strong recommendation means that it can be adapted as a policy in most situations.
[2] Determination of vitamin A deficiency as a public health problem involves estimating the prevalence of deficiency in a population by using specific biochemical and clinical indicators of vitamin A status. Classification of countries based on the most recent estimates is available in reference.Source : WHO
No comments:
Post a Comment